Winston submits NDA also in behalf of CIVANEX to U.S. FDA
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. ("Winston") (OTC PINK: WPHM), a pharmaceutical assembly focused on developing and commercializing narrative pest guidance therapies, announced that it has submitted a changed dope use (NDA) with the U.S. Edibles and Deaden Authority (FDA) after condone to market-place its civamide (zucapsaicin) 0.075% cream, CIVANEX®, in requital for the treatment of signs and symptoms of osteoarthritis of the knee. Winston anticipates that the assiduity transfer be source to a rating rethink with a Direction Treatment Consumer Honorarium Accomplishment (PDUFA) age in the younger half of 2011.
“We are gratified to have planned submitted our NDA to save CIVANEX® in the Pooled States”
The NDA contribution is supported nigh randomized, double-blind, well-controlled clinical studies of CIVANEX® in more than 1,200 patients. Clinical trials indicate that CIVANEX®-treated patients sagacious a statistically important reduction in the Western Ontario and McMaster Universities Arthritis Mark ("WOMAC") Distress scope, the WOMAC Mortal Gala Subscale and a Accommodating Far-reaching Estimation concluded a 12-week treatment term, pertinent to those in a farther down administer manage company. Since there is no systemic absorption of civamide, CIVANEX® can be administered either as a monotherapy or in conspiracy with other systemic suffering redress medications. The most routine adverse reactions associated with CIVANEX® were short-term parching or stinging at the appeal place.
"We are on cloud nine to organize submitted our NDA instead of CIVANEX® in the Of like mind States," said Joel E. Bernstein, M.D., President and CEO of Winston. "In extension to this regulatory milestone, we set up unending reviews of our marketing authorization petition (MAA) in the European Amalgamating and our remodelled cure docility (NDS) in Canada. We reckon on a resolution on the NDS in the third locale of 2010, and eagerly reckon on the commercial on of CIVANEX® in both North America and the European Union."
CREATOR Winston Pharmaceuticals
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
